Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Rauramaa

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Neurobiology of Disease|April 29, 2023
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture modelsRebekka Wittrahm, Mari Takalo, Teemu Kuulasmaa, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Molecular Neurodegeneration|April 29, 2025
Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's diseaseHenna Martiskainen, Roosa-Maria Willman, Päivi Harju, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Neuropathology and Applied Neurobiology|April 8, 2025
Comparative Clinical and Imaging-Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL AmplificationMichaela-Kristina Keck, Anna Tietze, Brigitte Bison, et al.
Nature Medicine|March 31, 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's diseaseHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Neurobiology of Disease|April 29, 2023
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture modelsRebekka Wittrahm, Mari Takalo, Teemu Kuulasmaa, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Molecular Neurodegeneration|April 29, 2025
Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's diseaseHenna Martiskainen, Roosa-Maria Willman, Päivi Harju, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Neuropathology and Applied Neurobiology|April 8, 2025
Comparative Clinical and Imaging-Based Evaluation of Therapeutic Modalities in CNS Embryonal Tumours With PLAGL AmplificationMichaela-Kristina Keck, Anna Tietze, Brigitte Bison, et al.
Nature Medicine|March 31, 2025
A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer's diseaseHamilton Se-Hwee Oh, Deniz Yagmur Urey, Linda Karlsson, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Non-microglial downregulation of <i>PLCG2</i> impairs synaptic function and elicits Alzheimer disease-related hallmarksAudrey Coulon, Florian Rabiller, Mari Takalo, et al.
Pageof 8